Skip to main content

STK-03: Anticoagulation Therapy for Atrial Fibrillation/Flutter

CBE ID
0436e
1.4 Project
Neurology
Endorsement Status
Not Endorsed
E&M Cycle
Full Year 2015
Is Under Review
No
1.3 Measure Description

This measure captures the proportion of ischemic stroke patients with atrial fibrillation/flutter who are prescribed anticoagulation therapy at hospital discharge.

This measure is a part of a set of eight nationally implemented measures that address stroke care (STK-1: Venous Thromboembolism (VTE) Prophylaxis, STK-2: Discharged on Antithrombotic Therapy, STK-4: Thrombolytic Therapy, STK-5: Antithrombotic Therapy By End of Hospital Day 2, STK-6 Discharged on Statin Medication, STK-8: Stroke Education, and STK-10: Assessed for Rehabilitation) that are used in The Joint Commission’s hospital accreditation and Disease-Specific Care certification programs. STK-3, Anticoagulation Therapy for Atrial Fibrillation/Flutter, is one of six of the measures in this set that have been reengineered as eCQMs and are included in the EHR Incentive Program and Hospital Inpatient Quality Reporting Program.

    • 1.14 Numerator

      Patients prescribed anticoagulation therapy at hospital discharge.

    • 1.15 Denominator

      Patients with a principal diagnosis of ischemic stroke, history of atrial ablation, and current or history of atrial fibrillation/flutter.

    • Exclusions

      Denominator Exclusions:
      • Patients with comfort measures documented.
      • Patients admitted for elective carotid intervention. This exclusion is implicitly modeled by only including non-elective hospitalizations.
      • Patients discharged to another hospital.
      • Patients who left against medical advice.
      • Patients who expired.
      • Patients discharged to home for hospice care.
      • Patients discharged to a health care facility for hospice care.

      Denominator Exceptions:
      • Patients with a documented reason for not prescribing anticoagulation therapy at discharge.

    • Most Recent Endorsement Activity
      Not Endorsed Neurology Project 2015-2016
    • Steward
      The Joint Commission
      Steward Organization Email
      [email protected]
      Steward Organization Copyright

      Measure specifications are in the Public Domain

      LOINC(R) is a registered trademark of the Regenstrief Institute.

      This material contains SNOMED Clinical Terms (R) (SNOMED CT(c)) copyright 2004-2014 International Health Terminology Standards Development Organization. All rights reserved.